NCT02752503 Nalmefene in Alcohol Dependence and Borderline Personality Disorder Status UNKNOWN Phase NA
NCT02742532 Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress Status COMPLETED Phase PHASE2
NCT02664766 Effects of Long-term Exercise on Various Parameters in Heavy Drinkers Status COMPLETED Phase NA
NCT02664727 Effects of Acute Exercise on Various Parameters in Individuals With Alcohol Use Disorders Status COMPLETED Phase NA
NCT02652195 Deciphering the Role of Oxytocin in Motivation: an fMRI Study. Part II Status UNKNOWN Phase PHASE2
NCT02646449 Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial Status COMPLETED Phase PHASE2
NCT02600832 AABM to Decrease Problem Drinking and Impulsivity in Veterans With AUD: A Pilot Study Status COMPLETED Phase NA
NCT02598518 Integrating Combined Therapies for Persons With Co-occurring Disorders Status COMPLETED Phase NA
NCT02596763 Phone-based Safety Monitoring of Baclofen Prescriptions for Alcohol Use Disorder Status TERMINATED Phase PHASE4
NCT02582905 Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders Status COMPLETED Phase PHASE4
NCT02544581 Preliminary Analysis of the Soberlink Alcohol Breath Analyzer System's (SABA) Clinical Utility During Aftercare Status UNKNOWN Phase N/A
NCT02511886 A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use Disorder Status COMPLETED Phase PHASE2